Do cost-sharing and entry deregulation curb pharmaceutical innovation?

presented at CESifo Area Conference on Public Sector Economics, April 2011

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Do cost-sharing and entry deregulation curb p ...
Volker Grossmann
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

Buy this book

Last edited by MARC Bot
June 30, 2022 | History

Do cost-sharing and entry deregulation curb pharmaceutical innovation?

presented at CESifo Area Conference on Public Sector Economics, April 2011

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

This edition doesn't have a description yet. Can you add one?

Publish Date
Publisher
CESifo
Language
English
Pages
41

Buy this book

Book Details


Edition Notes

Literaturangaben. - Zusätzliches Online-Angebot unter www.SSRN.com, www.RePEc.org und www.CESifo-group.org/wp

Published in
Munich
Series
CESifo working papers -- No. 3439 : Category 1, Public finance

Classifications

Dewey Decimal Class
650, 330

The Physical Object

Pagination
41 S.
Number of pages
41

ID Numbers

Open Library
OL38579022M
OCLC/WorldCat
748702146
Deutsche National Bibliothek
1013105362

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
June 30, 2022 Created by MARC Bot import new book